Compare $CDIO vs $XBIO | Chartloom

Compare

$CDIO vs $XBIO

Cardio Diagnostics Holdings Inc · Xenetic Biosciences Inc

CDIO

Cardio Diagnostics Holdings Inc

XBIO

Xenetic Biosciences Inc

Compare $CDIO vs $XBIO

Comparing Cardio Diagnostics Holdings Inc and Xenetic Biosciences Inc

CDIOCardio Diagnostics Holdings Inc

XBIOXenetic Biosciences Inc

CDIOCardio Diagnostics Holdings Inc

Market cap

$6M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-25.1%

YTD performance

-34.2%

52W performance

-58.8%

FCF yield

-110.3%

XBIOXenetic Biosciences Inc

Market cap

$5M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

33.3%

YTD performance

-0.9%

52W performance

-79.4%

FCF yield

-47.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CDIO

XBIO

Detailed metrics comparison

CDIO

Cardio Diagnostics Holdings Inc

XBIO

Xenetic Biosciences Inc

Market Cap

CDIO$6M

XBIO$5M

Enterprise Value

CDIO$16K

XBIO$-2M

Price

CDIO$1.87

XBIO$2.13

P/E Ratio

CDION/A

XBION/A

P/S Ratio

CDIO379.12x

XBIO1.50x

EV/Sales

CDIO1.10x

XBIO-0.49x

EV/EBITDA

CDIO0.00x

XBIO0.00x

P/B Ratio

CDIO0.78x

XBIO0.81x

P/FCF Ratio

CDION/A

XBION/A

EV/FCF

CDIO-0.00x

XBIO0.69x

PEG Ratio

CDION/A

XBION/A

Forward P/E (NTM)

CDION/A

XBION/A

Forward P/S (NTM)

CDION/A

XBION/A

Revenue (TTM)

CDIO$15K

XBIO$3M

Revenue Growth (YoY)

CDIO-25.1%

XBIO33.3%

Forward Rev Growth

CDIO0.0%

XBIO-16.7%

Gross Margin (TTM)

CDIO0.0%

XBIO98.7%

Operating Margin (TTM)

CDIO0.0%

XBIO0.0%

EBITDA Margin (TTM)

CDIO-41671.2%

XBIO-81.0%

Net Margin (TTM)

CDIO-44312.3%

XBIO-75.9%

FCF Margin (TTM)

CDIO-41825.3%

XBIO-70.9%

Net Income (TTM)

CDIO$-6M

XBIO$-2M

FCF (TTM)

CDIO$-6M

XBIO$-2M

EPS (TTM)

CDIO-$2.19

XBIO-$1.08

ROE (TTM)

CDIO-8227.0%

XBIO-4062.0%

ROA (TTM)

CDIO-7602.0%

XBIO-3497.0%

ROIC (TTM)

CDIO-8097.0%

XBIO-4062.0%

Cash

CDIO$6M

XBIO$6M

Debt

CDIO$68K

XBIO$0

Net Cash/Debt

CDIO$6M

XBIO$6M

Current Ratio (TTM)

CDIO17.15x

XBIO7.43x

Quick Ratio (TTM)

CDIO15.56x

XBIO7.23x

Debt/Equity (TTM)

CDIO0.01x

XBIO0.00x

Debt/Assets (TTM)

CDIO0.0%

XBIO0.0%

Interest Coverage (TTM)

CDION/A

XBION/A

Net Debt/EBITDA (TTM)

CDIO0.00x

XBIO0.00x

Beta

CDIO2.30

XBIO2.36

52W Performance

CDIO-58.8%

XBIO-79.4%

YTD Performance

CDIO-34.2%

XBIO-0.9%

% from 52W High

CDIO-76.4%

XBIO-79.2%

% from 52W Low

CDIO92.8%

XBIO13.9%

Asset Turnover (TTM)

CDIO0.00x

XBIO0.46x

FCF Yield (TTM)

CDIO-110.3%

XBIO-47.4%

Earnings Yield (TTM)

CDIO-116.9%

XBIO-50.7%

Dividend Yield (TTM)

CDION/A

XBION/A

Rule of 40

CDIO-41,850.5

XBIO-37.6

EV/GP/RG

CDION/A

XBION/A

Ticker research

View CDIO research View XBIO research

Metric	CDIO Cardio Diagnostics Holdings Inc	XBIO Xenetic Biosciences Inc
Market & Valuation
Market Cap	$6M	$5M
Enterprise Value	$16K	$-2M
Price	$1.87	$2.13
P/E Ratio	N/A	N/A
P/S Ratio	379.12x	1.50x
EV/Sales	1.10x	-0.49x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.78x	0.81x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.00x	0.69x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$15K	$3M
Revenue Growth (YoY)	-25.1%	33.3%
Forward Rev Growth	0.0%	-16.7%
Profitability
Gross Margin (TTM)	0.0%	98.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-41671.2%	-81.0%
Net Margin (TTM)	-44312.3%	-75.9%
FCF Margin (TTM)	-41825.3%	-70.9%
Net Income (TTM)	$-6M	$-2M
FCF (TTM)	$-6M	$-2M
EPS (TTM)	-$2.19	-$1.08
ROE (TTM)	-8227.0%	-4062.0%
ROA (TTM)	-7602.0%	-3497.0%
ROIC (TTM)	-8097.0%	-4062.0%
Financial Health
Cash	$6M	$6M
Debt	$68K	$0
Net Cash/Debt	$6M	$6M
Current Ratio (TTM)	17.15x	7.43x
Quick Ratio (TTM)	15.56x	7.23x
Debt/Equity (TTM)	0.01x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.30	2.36
52W Performance	-58.8%	-79.4%
YTD Performance	-34.2%	-0.9%
% from 52W High	-76.4%	-79.2%
% from 52W Low	92.8%	13.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.46x
FCF Yield (TTM)	-110.3%	-47.4%
Earnings Yield (TTM)	-116.9%	-50.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-41,850.5	-37.6
EV/GP/RG	N/A	N/A
Ticker research	View CDIO research	View XBIO research

Valuation

P/S Ratio

XBIO

1.50x

CDIO

379.12x

EV/FCF

CDIO

-0.00x

XBIO

0.69x

Growth & revenue

Revenue Growth TTM

XBIO

33.3%

CDIO

-25.1%

Forward Revenue Growth

CDIO

0.0%

XBIO

-16.7%

Profitability & performance

Gross Margin

XBIO

98.7%

CDIO

0.0%

ROE

XBIO

-4062.0%

CDIO

-8227.0%

FCF Yield %

XBIO

-47.4%

CDIO

-110.3%

52-Week Performance

CDIO

-58.8%

XBIO

-79.4%

Detailed metrics comparison

CDIO

Cardio Diagnostics Holdings Inc

XBIO

Xenetic Biosciences Inc

Market Cap

CDIO$6M

XBIO$5M

Enterprise Value

CDIO$16K

XBIO$-2M

Price

CDIO$1.87

XBIO$2.13

P/E Ratio

CDION/A

XBION/A

P/S Ratio

CDIO379.12x

XBIO1.50x

EV/Sales

CDIO1.10x

XBIO-0.49x

EV/EBITDA

CDIO0.00x

XBIO0.00x

P/B Ratio

CDIO0.78x

XBIO0.81x

P/FCF Ratio

CDION/A

XBION/A

EV/FCF

CDIO-0.00x

XBIO0.69x

PEG Ratio

CDION/A

XBION/A

Forward P/E (NTM)

CDION/A

XBION/A

Forward P/S (NTM)

CDION/A

XBION/A

Revenue (TTM)

CDIO$15K

XBIO$3M

Revenue Growth (YoY)

CDIO-25.1%

XBIO33.3%

Forward Rev Growth

CDIO0.0%

XBIO-16.7%

Gross Margin (TTM)

CDIO0.0%

XBIO98.7%

Operating Margin (TTM)

CDIO0.0%

XBIO0.0%

EBITDA Margin (TTM)

CDIO-41671.2%

XBIO-81.0%

Net Margin (TTM)

CDIO-44312.3%

XBIO-75.9%

FCF Margin (TTM)

CDIO-41825.3%

XBIO-70.9%

Net Income (TTM)

CDIO$-6M

XBIO$-2M

FCF (TTM)

CDIO$-6M

XBIO$-2M

EPS (TTM)

CDIO-$2.19

XBIO-$1.08

ROE (TTM)

CDIO-8227.0%

XBIO-4062.0%

ROA (TTM)

CDIO-7602.0%

XBIO-3497.0%

ROIC (TTM)

CDIO-8097.0%

XBIO-4062.0%

Cash

CDIO$6M

XBIO$6M

Debt

CDIO$68K

XBIO$0

Net Cash/Debt

CDIO$6M

XBIO$6M

Current Ratio (TTM)

CDIO17.15x

XBIO7.43x

Quick Ratio (TTM)

CDIO15.56x

XBIO7.23x

Debt/Equity (TTM)

CDIO0.01x

XBIO0.00x

Debt/Assets (TTM)

CDIO0.0%

XBIO0.0%

Interest Coverage (TTM)

CDION/A

XBION/A

Net Debt/EBITDA (TTM)

CDIO0.00x

XBIO0.00x

Beta

CDIO2.30

XBIO2.36

52W Performance

CDIO-58.8%

XBIO-79.4%

YTD Performance

CDIO-34.2%

XBIO-0.9%

% from 52W High

CDIO-76.4%

XBIO-79.2%

% from 52W Low

CDIO92.8%

XBIO13.9%

Asset Turnover (TTM)

CDIO0.00x

XBIO0.46x

FCF Yield (TTM)

CDIO-110.3%

XBIO-47.4%

Earnings Yield (TTM)

CDIO-116.9%

XBIO-50.7%

Dividend Yield (TTM)

CDION/A

XBION/A

Rule of 40

CDIO-41,850.5

XBIO-37.6

EV/GP/RG

CDION/A

XBION/A

Ticker research

View CDIO research View XBIO research

Metric	CDIO Cardio Diagnostics Holdings Inc	XBIO Xenetic Biosciences Inc
Market & Valuation
Market Cap	$6M	$5M
Enterprise Value	$16K	$-2M
Price	$1.87	$2.13
P/E Ratio	N/A	N/A
P/S Ratio	379.12x	1.50x
EV/Sales	1.10x	-0.49x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.78x	0.81x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.00x	0.69x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$15K	$3M
Revenue Growth (YoY)	-25.1%	33.3%
Forward Rev Growth	0.0%	-16.7%
Profitability
Gross Margin (TTM)	0.0%	98.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-41671.2%	-81.0%
Net Margin (TTM)	-44312.3%	-75.9%
FCF Margin (TTM)	-41825.3%	-70.9%
Net Income (TTM)	$-6M	$-2M
FCF (TTM)	$-6M	$-2M
EPS (TTM)	-$2.19	-$1.08
ROE (TTM)	-8227.0%	-4062.0%
ROA (TTM)	-7602.0%	-3497.0%
ROIC (TTM)	-8097.0%	-4062.0%
Financial Health
Cash	$6M	$6M
Debt	$68K	$0
Net Cash/Debt	$6M	$6M
Current Ratio (TTM)	17.15x	7.43x
Quick Ratio (TTM)	15.56x	7.23x
Debt/Equity (TTM)	0.01x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.30	2.36
52W Performance	-58.8%	-79.4%
YTD Performance	-34.2%	-0.9%
% from 52W High	-76.4%	-79.2%
% from 52W Low	92.8%	13.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.46x
FCF Yield (TTM)	-110.3%	-47.4%
Earnings Yield (TTM)	-116.9%	-50.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-41,850.5	-37.6
EV/GP/RG	N/A	N/A
Ticker research	View CDIO research	View XBIO research